The 2023 Psychedelic Industry Landscape with Psychedelic Alpha
Feb 27, 2023
auto_awesome
Josh Hardman, founder of Psychedelic Alpha, delves into the evolving psychedelic industry landscape, job opportunities, challenges in fundraising, therapy protocols, investor sentiment, and the significance of reciprocity and collaboration in the industry.
Psychedelic Alpha bridges history with current renaissance, focusing on non-hallucinogenic psychedelics and policy reform.
Thematic focus includes media, policy, and knowledge gaps with organic selection based on industry news.
Balance between public benefit and private profit in drug development, emphasizing accessibility and cost-effectiveness of therapies.
Deep dives
Josh Hardman's Background and Journey to Creating Psychedelic Alpha
Josh Hardman shared his journey from studying social history to founding Psychedelic Alpha, bridging the history of psychedelics with the current renaissance. Psychedelic Alpha focuses on thematic topics like non-hallucinogenic psychedelics and policy reform, aiming for respect and authority within the community.
Strategizing Themes for Psychedelic Alpha's Content
Psychedelic Alpha's thematic focus involves looking at popular media articles, policy reforms, company news, and addressing knowledge gaps. Themes are selected organically based on the constant influx of news and data in the psychedelic space.
Commercialization Paths of Companies like Maps and Compass Pathways
Analyzing the commercialization paths of companies such as Maps and Compass Pathways revealed the benefits of private funding in terms of pace and scale. The discussion highlighted the balance between public benefit and private profit in the context of drug development.
Accessibility and Cost-Effectiveness of Psychedelic Therapies
The shift from focusing on drug approvals to accessibility of therapies raised important questions about costs, insurance coverage, and off-label prescribing. Evaluating the cost-effectiveness of psychedelic therapies and addressing payer considerations emerged as critical factors.
Career Opportunities and Future Industry Trends
Exploration of career opportunities in the psychedelic industry revealed the need for a blend of scientific and commercial expertise. Start-up experience can be valuable, with roles available in drug discovery, technology, and clinic infrastructure. Emphasizing the importance of early research engagement and sharing innovative ideas was encouraged for industry growth.
In this week’s episode, Greg and Matias chat with Josh Hardman, the founder of Psychedelic Alpha.
Josh is a leading writer and founder at Psychedelic Alpha, an online resource, newsletter, and community covering the intersection of psychedelics and business. He regularly collaborates and writes with experts in the psychedelic field including entrepreneurs, academic researchers, non-profits, and more to provide a comprehensive understanding of the latest developments in the industry. Psychedelic Alpha recently released Psychedelics 2022: A Year in Review to comment on and analyze the industry across research, funding, and policy.